The list of challenges associated with commercializing a product is long and diverse. Every decision seems to affect patient access to your product and has long-term implications on growth and profitability. Too often manufacturers make commercialization decisions, negotiate agreements, and set prices that aren’t fully understood with the benefit of experience or solid analytics. 

In this webinar, IntegriChain Payer & Market Access Segment Leader David Carlson draws on unique insights and best practices learned as part of dozens of successful small molecule retail and specialty product launches to analyze the most significant commercialization hurdles. Topics discussed include:

• Contracting – PBM and Payer contracting decisions based on instinct rather than market insights
• Negotiating Discounts – Inability to properly weigh trade offs to determine how discounts impact access (market share)
• Pricing – Lack of historical and market data to quantify the financial impact of pricing decisions
• Measuring Channel Performance – Limited visibility to product in the channel (sales inventory & demand trends) during and after launch